Articles From: OceanFirst Financial Corp. Schedules Earnings Conference Call to Ocular Therapeutix Announces Second Quarter 2014 Financial Results


TOMS RIVER, N.J., Sept.
Sign-up for OceanFirst Financial Corp. Schedules Earnings Conference Call investment picks
TOMS RIVER, N.J., July 25, 2014 (GLOBE NEWSWIRE) -- OceanFirst Financial Corp.
Sign-up for OceanFirst Financial Corp. to Present at Keefe Bruyette & Woods Community Bank Investor Conference investment picks
PALO ALTO, Calif., Aug.
Sign-up for Ocera Announces Appointment of Rajiv Patni, M.D. as Chief Development Officer investment picks
PALO ALTO, Calif., Aug.
Sign-up for Ocera Reports Second Quarter 2014 Financial Results investment picks
PALO ALTO, Calif., Sept.
Sign-up for Ocera Therapeutics Announces Appointment of Steven P. James to Board investment picks
PALO ALTO, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX) , a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that it will release its second quarter financial results on August 11, 2014 at approximately 4:00 p.m. Eastern Time.
Sign-up for Ocera Therapeutics to Announce Second Quarter Financial Results investment picks
PALO ALTO, Calif., Nov.
Sign-up for Ocera Therapeutics to Announce Third Quarter 2014 Financial Results investment picks
PALO ALTO, Calif., Sept.
Sign-up for Ocera Therapeutics to Present at 13th Annual BIO Investor Forum investment picks
PALO ALTO, Calif., Nov.
Sign-up for Ocera Therapeutics to Present at Stifel 2014 Healthcare Conference investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G024273-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/21/11G024273/Och-Ziff_LOGO_CMYKgreen2011-1288844306723.jpg NEW YORK, NY--(Marketwired - October 21, 2014) - Och-Ziff Capital Management Group LLC (NYSE: OZM) (the "Company") plans to announce its results and dividend for the 2014 third quarter on Tuesday, November 4, 2014 in a press release that will be issued prior to the opening of the New York Stock Exchange.
Sign-up for Och-Ziff Capital Management Group LLC to Release 2014 Third Quarter Results and Announce 2014 Third Quarter Dividend on November 4, 2014 investment picks
NEDERLAND, Texas , Aug.
Sign-up for OCI Partners LP Restarts its Beaumont Facility after Conducting Repairs on the Reformer investment picks
2014/11/5
NEDERLAND, Texas , Nov.
Sign-up for OCI Partners LP Schedules 2014 Third Quarter Results Conference Call investment picks
OCI Resources LP (the "Partnership") (NYSE: OCIR) announced today the approval of an increase of 5% in the distribution to be paid to unitholders and the approval of its quarterly distribution by the board of directors of its general partner.
Sign-up for OCI Resources LP Declares Quarterly Cash Distribution investment picks
OCI Resources LP (NYSE: OCIR) announced today that it will release third quarter 2014 financial results after the market closes Tuesday, November 4, 2014.
Sign-up for OCI Resources LP To Release Third Quarter 2014 Financial Results investment picks
SAN JOSE, Calif.
Sign-up for Oclaro Announces First Quarter Fiscal Year 2015 Financial Results investment picks
SAN JOSE, Calif.
Sign-up for Oclaro Announces Fourth Quarter Fiscal Year 2014 Financial Results investment picks
Represents the Industry's Smallest Coherent Pluggable Module with the Lowest Power Consumption CANNES, France and SAN JOSE, Calif.
Sign-up for Oclaro Demonstrates the Industry's First 200G Coherent CFP2 Pluggable Transceiver at ECOC 2014 investment picks
Highlights Oclaro's Leadership Position in High-Volume CFP/CFP2 Shipments CANNES, France and SAN JOSE, Calif.
Sign-up for Oclaro to Expand Manufacturing Capacity of 100G Client Side Pluggable Optics; Unveils 2nd Generation CFP2 investment picks
Product Offerings Highlight Oclaro's Leadership Position in Coherent Pluggable Transceivers, Components and 100G Client Side Pluggable Optics SAN JOSE, Calif.
Sign-up for Oclaro to Showcase Strong 100G Line-up at ECOC 2014 investment picks
2014/10/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1149837&ProfileId=051205&sourceType=1 ALEXANDRIA, LA --
Sign-up for OCLG Continues Debt Reduction Strategy; Strengthens Company's Stock Position and Shareholder Value investment picks
Oconee Federal Financial Corp.
Sign-up for Oconee Federal Financial Corp. Announces Three Month and Year Ended Financial Results investment picks
2014/11/3
LONDON , November 3, 2014 /PRNewswire/ -- Chrysler Automobiles announces that Chrysler Group LLC released today, through PR Newswire, US retail sales in October 2014 .
Sign-up for October 2014 Chrysler Group LLC Sales in USA investment picks
Cars.com reports SUV and truck sales propel new-car market to YTD highs CHICAGO , Nov.
Sign-up for October Average Transaction Price Reaches Highest Mark of 2014 investment picks
2014/10/2
October Events! Justin Trudeau in Conversation With Heather Reisman, Bobby Orr, Chris Hadfield and IndigoKids Open House Canada NewsWire OCTOBER EVENTS AT INDIGO BOOKS & MUSIC TORONTO , Oct.
Sign-up for October Events! Justin Trudeau in Conversation With Heather Reisman, Bobby Orr, Chris Hadfield and IndigoKids Open House investment picks
By Tess Stynes American Airlines Group Inc. and Southwest Airlines Co.
Sign-up for October traffic edges up at American, Southwest investment picks
ADVISORY, July 31, 2014 (GLOBE NEWSWIRE) -- What: Ocular Therapeutix (Nasdaq:OCUL) , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, will visit the NASDAQ MarketSite in Times Square in celebration of its initial public offering (IPO) which occurred on The NASDAQ Stock Market on July 25, 2014.
Sign-up for Ocular Therapeutix (NASDAQ: OCUL) to Ring The NASDAQ Stock Market Closing Bell investment picks
Ocular Therapeutix (Nasdaq: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, announced today that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 750,000 shares at the initial public offering price of $13.00 per share, less underwriting discounts.
Sign-up for Ocular Therapeutix Announces Exercise of Over-Allotment Option investment picks
Ocular Therapeutix (Nasdaq: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the second quarter ended June 30, 2014.
Sign-up for Ocular Therapeutix Announces Second Quarter 2014 Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: OceanFirst Financial Corp. Schedules Earnings Conference Call to Ocular Therapeutix Announces Second Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent